We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Donaldson
DCI
$11.1B
| $2.44M | 0.01% |
33,132
+12,000
| +57% | +$868K |
|
602
Charles River Laboratories
CRL
$13.4B
| $2.41M | 0.01% |
12,237
+1,900
| +18% | +$395K |
|
603
Match Group
MTCH
$8.55B
| $2.39M | 0.01% |
63,100
+10,100
| +19% | +$353K |
|
604
Starwood Property Trust
STWD
$6.03B
| $2.38M | 0.01% |
116,597
+29,200
| +33% | +$583K |
|
605
Primerica
PRI
$9.63B
| $2.37M | 0.01% |
8,937
| – | – |
|
606
Lithia Motors
LAD
$8.35B
| $2.37M | 0.01% |
7,458
+1,800
| +32% | +$502K |
|
607
Ingredion
INGR
$6.64B
| $2.37M | 0.01% |
17,230
+3,000
| +21% | +$382K |
|
608
Crocs
CROX
$6.33B
| $2.36M | 0.01% |
16,300
+2,400
| +17% | +$328K |
|
609
Encompass Health
EHC
$12.2B
| $2.35M | 0.01% |
24,353
+3,400
| +16% | +$306K |
|
610
Globant
GLOB
$1.77B
| $2.34M | 0.01% |
11,800
+3,500
| +42% | +$676K |
|
611
Mohawk Industries
MHK
$9.42B
| $2.33M | 0.01% |
14,511
+5,300
| +58% | +$763K |
|
612
Chemed
CHE
$7.02B
| $2.33M | 0.01% |
3,872
+300
| +8% | +$170K |
|
613
Old Republic International
ORI
$10.3B
| $2.33M | 0.01% |
65,671
+16,600
| +34% | +$562K |
|
|
WBA
614
DELISTED
Walgreens Boots Alliance
WBA
| $2.33M | 0.01% |
259,589
| – | – |
|
615
MarketAxess Holdings
MKTX
$5.72B
| $2.32M | 0.01% |
9,044
+1,300
| +17% | +$305K |
|
|
DAY
616
DELISTED
Dayforce
DAY
| $2.31M | 0.01% |
37,800
+7,200
| +24% | +$397K |
|
617
FMC
FMC
$1.27B
| $2.31M | 0.01% |
35,100
+9,500
| +37% | +$582K |
|
618
Toast
TOST
$20.3B
| $2.3M | 0.01% |
81,400
| – | – |
|
619
AGNC Investment
AGNC
$13B
| $2.3M | 0.01% |
220,100
| – | – |
|
620
H&R Block
HRB
$6.72B
| $2.29M | 0.01% |
36,100
+7,400
| +26% | +$441K |
|
621
Norwegian Cruise Line
NCLH
$8.94B
| $2.29M | 0.01% |
111,600
+23,100
| +26% | +$419K |
|
622
DaVita
DVA
$11.5B
| $2.28M | 0.01% |
13,900
+1,700
| +14% | +$251K |
|
623
Globe Life
GL
$14.1B
| $2.28M | 0.01% |
21,500
+7,300
| +51% | +$700K |
|
624
Domino's
DPZ
$11.6B
| $2.27M | 0.01% |
5,278
| – | – |
|
625
Aramark
ARMK
$16.1B
| $2.27M | 0.01% |
58,500
+9,500
| +19% | +$335K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.